GLP-1 Receptor Agonist

Who funds Ozempic research?

Direct Answer

The major clinical trials for Ozempic (SUSTAIN program, STEP trials) were funded by Novo Nordisk, the manufacturer. This is standard practice in pharmaceutical research — most pivotal trials are industry-funded. While industry funding does not automatically invalidate results (they undergo the same FDA review), it is worth knowing because industry-sponsored trials are statistically more likely to report favorable outcomes. Novo Nordisk has also made significant payments to physicians and researchers through programs tracked by CMS Open Payments.

Based on published clinical trial data and FDA prescribing information. This is not medical advice — always consult your healthcare provider.

Supporting Evidence

Funding & Conflicts

STEP trials and most published semaglutide research were funded by Novo Nordisk, which reported approximately $38.6B in semaglutide revenue in 2023. Lead investigators received advisory board fees, consulting payments, and travel support from Novo Nordisk and other pharmaceutical companies.

Conflicts of Interest

Key opinion leaders in obesity and diabetes research receive consulting fees ranging $50k-500k+ annually from GLP-1 manufacturers. American Diabetes Association receives millions in pharmaceutical funding. Most major review articles and clinical practice guidelines authored by researchers with declared pharmaceutical conflicts of interest. Marketing budget for GLP-1 drugs exceeds $3B+ annually.

Clinical Trials

Expected HbA1c reduction: −1.5% to −1.8% from baseline (SUSTAIN trials, 0.5–2mg). Weight loss: −9–14 lbs. Wegovy (2.4mg/wk): −14.9% body weight (STEP-1). Lifestyle comparison: dietary intervention alone reduces diabetes risk by 58% (DPP trial). Oral semaglutide (OW3 9mg): −1.5–1.7% HbA1c in phase 3 trials.

Funding transparency: STEP trials and most published semaglutide research were funded by Novo Nordisk, which reported approximately $38.6B in semaglutide revenue in 2023. Lead investigators received advisory board fees, co See full funding details

Read the complete Ozempic® / Wegovy® / Rybelsus® guide

Side effect rates, clinical trial data, funding transparency, drug interactions, tapering protocols, and lifestyle alternatives — all in one place.

View Ozempic® / Wegovy® / Rybelsus®